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Introduction
Cushing’s disease, which implies an aetiological origin
in the pituitary, accounts for about 70% of all causes of
Cushing’s syndrome. Approximately 90% of adrenocortico-
tropic hormone (ACTH)-secreting pituitary adenomas
are less than 10 mm in diameter and some of them are
less than 3 mm.l,2 This characteristically small tumour
size often makes a neuroimaging diagnosis ambiguous, even
with the most advanced helical computed tomography
(CT) or magnetic resonance imaging (MRI). Thus, the
surgical indications are sometimes controversial. We
retrospectively analyzed our surgical experience, including
18 years of follow-up, for 87 cases of pituitary ACTH micro-
adenoma.
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Surgical Treatment and Follow-up Results of Pituitary
ACTH Microadenoma: 18 Years’ Experience
Patients and methods
From September 1984 to September 2000, 87 patients with
pituitary ACTH microadenomas underwent surgery via the
transsphenoidal approach, which accounted for 78% of all
surgically treated ACTH adenoma cases in the same period.
There were 67 women and 20 men, ranging in age from 16 to
53 years, with a mean of 33 years. The average duration of
illness before operation was 2.6 years. Clinically, all patients
had typical signs of Cushing’s syndrome. On biochemical
studies, absent diurnal cortisol rhythm with abnormally
high free cortisol levels in urine were found in all patients.
All patients had a high level of plasma cortisol, except for
four, whose cortisol level was just within the upper normal
limit. On dexamethasone (Dx) suppression testing,
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OBJECTIVE: To review retrospectively our clinical experience with surgical treatment and follow-up of
pituitary adrenocorticotropic hormone (ACTH) microadenomas at Rui Jin Hospital of Shanghai Second
Medical University.
METHODS: Eighty-seven patients with ACTH microadenomas underwent surgery via the transsphenoidal
approach. Preoperative computed tomography and/or magnetic resonance imaging revealed microadenomas in
only 46 patients and was negative in the remaining 41 patients, which were classified as microadenoma grade 0.
High-dose dexamethasone (Dx) suppression testing was positive in 86% of patients and low-dose Dx suppression
testing was negative in all patients.
RESULTS: Histological confirmation of ACTH microadenoma was made in all 87 cases, with a minimum tumour
size of only 1 to 2 mm in diameter. The remission rate was 82% for grade I and 92% for grade 0 microadenomas
during 2 to 18 years of follow-up.
CONCLUSIONS: Neuroimaging studies have limited value in diagnosing ACTH grade 0 microadenoma.
Clinical manifestation combined with positive Dx suppression testing is decisive in these circumstances. Surgical
intervention could achieve a high relief rate for ACTH microadenomas, especially in grade 0 group.  (Asian J Surg
2003;26(1):22–5)
23
ASIAN JOURNAL OF SURGERY  VOL 26 • NO 1 • JANUARY 2003 23
■ SURGICAL TREATMENT OF ACTH MICROADENOMA ■
the urine cortisol level could be suppressed by a high dose of
Dx (8 mg) in 86% of patients, but not by a low dose of 2 mg
in all cases. We believe this is a reliable and sensitive index
for screening of ACTH adenoma from Cushing’s syndrome
of other causes, such as Cushing’s syndrome of adrenal
origin. Peripheral ACTH concentrations were all within the
normal limits, except for three that were slightly higher
than reference value (12–78 pg/mL), with an average of 37 ±
23 pg/mL.
On neuroimaging studies, microadenomas were identified
by enhanced CT alone in 21 cases and by both CT and MRI in
25 cases. These cases were classified as grade I microadenomas.
The remaining 41 cases appeared normal on CT and MRI, with
normal contours of the sella turcica on 1-mm, thin-section
pluridirectional CT. These cases were grouped as grade 0
microadenomas. The average height of the pituitary
gland ranged from 6 mm for grade 0 to 9 mm for grade I.
Deviation of the pituitary stalk was found in 67% of grade I
microadenomas.
All operations were made through a sublabial or endonasal,
unilateral-septal transsphenoidal approach. Generally, after
opening the dura, yellowish semiliquid tumour tissue bulged
from the sellar. This was not the situation with most grade 0
microadenomas. Usually normal-appearing pinkish pituitary
tissue was first encountered after opening the dura of the
sellar floor. Careful exploration of the pituitary was then
made by horizontal and vertical incisions of the gland until a
tumour was found and confirmed by intraoperative frozen
section histology. In rare cases, when the texture and colour
of the adenoma tissue was suspicious and intraoperative
cytology did not reveal a definitive diagnosis of adenoma,
hemihypophysectomy was performed to ensure a successful
outcome.
Results
Surgical and pathological findings
Selective adenomectomy was achieved in 81 of 87 patients. Six
patients underwent hemihypophysectomy on the tumour side
either because the tumour was too tiny or its nature was
diffusely invasive, or because of an ambiguous intraoperative
diagnosis. Most of the adenomas were single in origin, but we
found multifocal tumours embedded in the pituitary glands
of four patients. Central wedge tumours were found in 39
patients, while the remaining tumours were found in the
lateral wings of the pituitary glands. The sizes of adenomas
extirpated are shown in the Table.  Intraoperative frozen
section revealed an adenoma diagnosis in 78 patients,
and postoperative histopathological confirmation of
microadenoma was made in all 87 patients, with minimal
tumour sizes as small as 1 to 2 mm in diameter. Immuno-
histochemical analyses were done in 49 cases, which showed
ACTH-positive staining in 52% and polyhormonal-positive
staining in 48% of all cases.
Complications and outcomes
All patients recovered well. There was no mortality or major
complication among the treated patients. Postoperative hypo-
pituitarism occurred in 11 patients, of which it was temporary
in eight; the remaining three patients required permanent
cortisone replacement therapy. Postoperative transient diabetes
insipidus occurred in four patients, and temporary cerebros-
pinal fluid rhinorrhoea occurred in another five patients.
There were nine patients with postoperative syndrome of
inappropriate secretion of antidiuretic hormone (SIADH). All
recovered well with proper management. Three patients had
complications of adrenoadenoma and underwent adrenoaden-
omectomy 4 months after their initial pituitary surgery.
Clinical and endocrinological remission was observed in
79 patients, including six patients in whom cortisol levels
normalized 2 to 4 months after surgery. Eight patients did not
benefit from pituitary surgery. This surgical failure might be
attributed to possible partial adenomectomy or multifocal
microadenomas in the pituitary, which were probably missed
during surgery.
Follow-up
Clinical and/or biochemical follow-up was performed on an
outpatient basis or by questionnaire in 69 out of 79 surgically
effective cases. Remission was defined as normalization of
Table. Size of adrenocorticotropic hormone microadenomas
surgically extirpated*
Diameter Microadenoma grade Total
0 I
< 2 mm 10 1 11
3–5 mm 32 13 45
6–9 mm 34 34
Total 42 48 90
*Includes multifocal microadenomas.
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extremely effective drug (bromocriptine) that can well control
the disease. Because there is no effective conservative remedy
for Cushing’s disease, aggressive surgical intervention is the
treatment of choice.
According to our experience, as long as the clinical and
biochemical diagnosis is correct, and a positive high-dose Dx
suppression test revealed disease of pituitary origin rather
than adrenal origin, surgical intervention is always indicated.
During the operation, correct visual interpretation of the
yellowish adenomatous tissue removed by an experienced
neurosurgeon is extremely important. The tumour tissue not
only differs from the surrounding pinkish normal pituitary
tissue, but also has a difference in texture, which is usually
crisp and easy to remove.
In some of our patients, Cushing’s disease was compli-
cated by adrenal adenomatous proliferation or nodular
adrenoadenoma. It is our policy to treat the pituitary adenoma
first and then monitor the patient closely for at least 3 to 4
months. Toms et al observed postoperative changes of cortisol
levels and found that there was still autonomous secretion of
cortisol by proliferated  adrenal cortex for 2 weeks after pituitary
ACTH adenomectomy, and the lowest serum cortisol level was
reached 6 to 12 weeks after the operation.6 Thus, only when
hypercortisolaemia has not resolved after that period is
adrenoadenomectomy indicated.
Conclusions
Imaging studies have limited value in diagnosing grade 0
ACTH microadenoma. Clinical manifestation combined with
a positive Dx suppression test is decisive in these circum-
stances. Even though radiographically occult, these minute
adenoma can be identified intraoperatively, selectively
extirpated, verified histologically and as a result, long-term
remission can be achieved for those otherwise medically
intractable patients.
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serum cortisol level and relief of Cushing’s symptoms. The
remission rate was 82% (27/33) for grade I and 92% (33/36) for
grade 0 microadenomas during the 2- to 18-year follow-up
period (mean, 7.5 yr). Nine patients had recurrences after
an apparent remission of as long as 5 years. They received
radiotherapy as an alternative treatment.
Discussion
Transsphenoidal microsurgery for the treatment of Cushing’s
disease is a standard procedure nowadays. With the
development of advanced imaging study techniques, more
pituitary microadenomas are clearly shown on thin-slice,
dynamic, enhanced CT or MRI. This makes the decision to
operate both reasonable and acceptable to patients, and good
results can be expected.3 To manage a case of pituitary adenoma
without imaging confirmation is difficult and remains a
challenge to neurosurgeons, who bear the responsibility if a
negative exploration is encountered.
Simultaneous venous sampling from both the inferior
petrosal sinuses (IPS) and a peripheral (P) vein for measurement
of ACTH production, with corticotropin-releasing hormone
stimulation, can be useful in diagnosing and localizing the
existence of intra-pituitary ACTH-secreting adenomas.4,5 The
test is considered positive for lateralization when the side-to-
side ACTH ratio is greater than 1.4 or when the peak IPS/P
ACTH ratio is greater than 3. Semple et al reported 91%
accuracy in predicting tumour location (side) as compared to
surgical findings,2 whereas others claimed to have only 50%
correlation with surgical findings.5 IPS sampling is not
routinely performed in many clinical practices due to its
inconvenient manipulation. Furthermore, it cannot replace
neurosurgical experience, which remains the most important
predictive factor for outcome in surgical management of
Cushing’s disease.
In Cushing’s disease, most ACTH-secreting adenomas are
microadenomas. As seen in our series of patients, nearly half
of the microadenomas could not be identified on MRI and/or
CT. The minimum size of a microadenoma detectable by MRI
is reported to be 3 mm. Nonetheless, the existence of tiny
adenomas less than 3 mm in diameter is not rare in cases of
Cushing’s disease. Should we rely on imaging diagnosis for
Cushing’s disease and delay surgery until the tumour is visible
on imaging studies? The answer is definitely “No.” Unlike the
case of prolactinoma, even when clinical and biological
evidence suggests the diagnosis, operation is reserved until
confirmed by neuroimaging studies because there is an
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